• 1
    Doona M, Walse JBUse of chloramphenicol as topical eye medication: time to cry halt?Br Med J1995; 310: 12171218
  • 2
    Mulla RJ, Barnes E, Rogers TRIs it time to stop using chloramphenicol on the eye? Fears are based on only six cases.Br Med J1995; 311: 450
  • 3
    Buckley RJK, Kirkness CM, Kanski JJ, Ridgway AEA, Tullo AB, Watson PGIs it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasia.Br Med J1995; 311: 450
  • 4
    Hall AV, Das SS, Tabaqchali SIs it time to stop using chloramphenicol on the eye? Risk is low in short courses.Br Med J1995; 311: 450451
  • 5
    Rayner SA, Buckley RJOcular chloramphenicol and aplastic anaemia. Is there a link?Drug Safety1996; 14: 273276
  • 6
    McGhee CNJ, Anastas CNWidespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?Br J Ophthalmol1996; 80: 182184
  • 7
    Rosenthal RL, Blackman ABone-marrow hypoplasia following use of chloramphenicol eye drops.JAMA1965; 191: 148149
  • 8
    Carpenter GChloramphenicol eye-drops and marrow aplasia.Lancet1975; 2: 326
  • 9
    Abrams SM, Degnan TJ, Vinciguerra VMarrow aplasia following topical application of chloramphenicol eye ointment.Arch Intern Med1980; 140: 576577
  • 10
    Fraunfelder FT, Bagby GC, Kelly DJFatal aplastic anemia following topical administration of ophthalmic chloramphenicol.Am J Ophthalmol1982; 93: 356360
  • 11
    Polak BCPChlooramfenical in de oogheelkunde.Geneesmiddelenbulletin1984; 18: 3133
  • 12
    Issaragrisil S, Piankijagum AAplastic anemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature.J Med Ass Thailand1985; 68: 309312
  • 13
    Elberg JJ, Hansen WHKloramfenikoløjendråber og aplastisk anaemi. Ugeskr Laeger1986; 148: 22272228
  • 14
    Fernández de Sevilla T, Alegre J, Vallespí T, Falcó V, Martínez-Vázquez JMAdult pure red cell aplasia following topical ocular chloramphenicol.Br J Ophthalmol1990; 74: 640
  • 15
    Brodsky E, Biger Y, Zfidan Z, Schneider MTopical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia.Israel J Med Sci1989; 25: 54
  • 16
    McWhae JA, Chang J, Lipton JHDrug-induced fatal aplastic anemia following cataract surgery.Can J Ophthalmol1992; 27: 313315
  • 17
    Flegg P, Cheong IWelsby PD. Chloramphenicol. Are concerns about aplastic anaemia justified?Drug Safety1992; 7: 167169
  • 18
    International Agranulocytosis and Aplastic Anemia StudyThe design of a study of the drug etiology of agranulocytosis and aplastic anemia.Eur J Clin Pharmacol1983; 24: 833836
  • 19
    Laporte JR, Capellà D, Juan JAgranulocytosis induced by cinepazide.Eur J Clin Pharmacol1990; 38: 387388
  • 20
    Ibáñez L, Juan J, Pérez E, Carné X, Laporte JRAgranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach.Eur Heart J1991; 12: 639641
  • 21
    Kaufman DW, Kelly JP, Levy M, Shapiro SThe drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press, 1991
  • 22
    Keisu M, Wiholm B-E, Öst A, Mortimer OAcetazolamide-associated aplastic anaemia.J Intern Med1990; 228: 627632
  • 23
    Wiholm B-E, Kelly JP, Kaufman D, Issaragrisil S, Levy M, Anderson T, Shapiro SDoes use of ocular chloramphenicol cause aplastic anaemia?Br Med J1998; 316: 666
  • 24
    Yunis AAChloramphenicol. Relation of structure to activity and toxicity.Ann Rev Pharmacol Toxicol1988; 28: 83100
  • 25
    Scruggs J, Wallace T, Hanna CRoute of absorption of drug and ointment after application to the eye.Ann Ophthalmol1978; 10: 267271